GAO Raises Additional Concerns With 340B Contract Pharmacies and Hospitals

The 340B drug discount program — a vital safety-net program created to help millions of vulnerable or uninsured patients receive care — is no longer benefiting many of the patients it was meant to serve. That’s according to mounting findings from congressional investigations, independent economists, and government watchdogs. Two new studies released by the Government Accountability Office (GAO) add to these growing concerns, looking specifically at contract pharmacies and hospitals in the 340B program. GAO’s latest conclusions provide further evidence more must be done to fix the 340B program and bring it back to the original intent of helping patients.